ENZN
Viskase Holdings, Inc.
Key Financials
Operating Income
$-5311000
↓ 300.2%
Net Income
$-3409000
↓ 538.2%
Revenue
$26000
0.0%
Total Assets
$42.8M
↓ 9.2%
EPS (Diluted)
$-0.07
↓ 600.0%
Shareholders' Equity
$-2525000.00
↓ 183.9%
Total Liabilities
$4.8M
↓ 11.7%
Cash & Equivalents
$42.6M
↓ 9.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/16/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| 4 | 3/27/2026 | View on SEC |
| SCHEDULE 13D/A | 3/27/2026 | View on SEC |
| 3 | 3/26/2026 | View on SEC |
| 3 | 3/26/2026 | View on SEC |
| 3 | 3/26/2026 | View on SEC |
| 3 | 3/26/2026 | View on SEC |
| 3 | 3/26/2026 | View on SEC |
| 3 | 3/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ENZN |
| Company Name | Viskase Holdings, Inc. |
| CIK | 727510 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (630) 874-0700 |